Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-cell Lymphoid Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00643240
What this trial is testing

Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 1
Not applicableLooking for participantsNCT06785818
What this trial is testing

Long-term Follow up Local Registry Study of Kymriah in South Korea

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma
Novartis Pharmaceuticals 500
Not applicableActive Not RecruitingNCT04159779
What this trial is testing

Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece

Who this might be right for
Chronic Lymphocytic Leukemia
AbbVie 180
Early research (Phase 1)Study completedNCT00058786
What this trial is testing

Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells

Who this might be right for
Chronic Lymphocytic B-Leukemia
Baylor College of Medicine 9
Very early researchStudy completedNCT03825718
What this trial is testing

GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Hebei Yanda Ludaopei Hospital 29
Not applicableUnknownNCT01298388
What this trial is testing

Study of Long-Term Outcomes of Patients With Acute Lymphoblastic Leukemia Who Were Enrolled as Children on Clinical Trials EORTC-58741, EORTC-58831, EORTC-58832, or EORTC-58881 Between 1971 and 1998

Who this might be right for
Cancer SurvivorLeukemiaLong-term Effects Secondary to Cancer Therapy in Children
European Organisation for Research and Treatment of Cancer - EORTC 3,138
Testing effectiveness (Phase 2)Study completedNCT02639910
What this trial is testing

Study to Evaluate Safety and Preliminary Efficacy of Tafasitamab With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
MorphoSys AG 24
Early research (Phase 1)Looking for participantsNCT04545762
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Refractory Non-Hodgkin LymphomaBurkitt LymphomaMantle Cell Lymphoma+7 more
C. Babis Andreadis 36
Testing effectiveness (Phase 2)Ended earlyNCT03594955
What this trial is testing

First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Leukaemia
Sanofi 7
Early research (Phase 1)Study completedNCT00304018
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of California, San Francisco 5
Early research (Phase 1)Study completedNCT00366418
What this trial is testing

Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia

Who this might be right for
Refractory Chronic Lymphocytic Leukemia
National Heart, Lung, and Blood Institute (NHLBI) 4
Not applicableNot Yet RecruitingNCT07371533
What this trial is testing

Clinical Study of Recombinant Anti-CD19m-CD3 Antibody Injection (A-319)

Who this might be right for
Acute Lymphocytic Leukemia
Shanxi Bethune Hospital 18
Large-scale testing (Phase 3)Study completedNCT00075725
What this trial is testing

Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia
Children's Oncology Group 3,154
Testing effectiveness (Phase 2)Ended earlyNCT00003910
What this trial is testing

Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 59
Early research (Phase 1)Study completedNCT00255710
What this trial is testing

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Ended earlyNCT03698552
What this trial is testing

ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Blasts 5 Percent or More of Bone Marrow Nucleated CellsCD22 PositivePhiladelphia Chromosome Positive+2 more
M.D. Anderson Cancer Center 37
Very early researchStudy completedNCT01184885
What this trial is testing

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

Who this might be right for
Lymphoid Malignancies (New or Relapsed)Acute Lymphoblastic LeukemiaBurkitt Lymphoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 7
Testing effectiveness (Phase 2)Study completedNCT01133743
What this trial is testing

Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
University Health Network, Toronto 31
Early research (Phase 1)Study completedNCT00387608
What this trial is testing

ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 23
Next Page